Science Explorer Interactive view Map
Company · Solna · Sweden

GlaxoSmithKline (Sweden)

se.gsk.comROR OpenAlex
Research works
39
▲ 56% vs 2013–17
Citations
910
23.0 per fractional work
Top-10% rate
18.2%
record average 16.5%
Open access
39%
world 28%

Not ranked overall: GlaxoSmithKline (Sweden) is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.83× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 0.22× its world share, 0 worksBiochemistry, Geneti…Immunology and Microbiology: 4.52× its world share, 0 worksImmunology and Micro…Pharmacology, Toxicology and Pharmaceutics: 2.47× its world share, 0 worksPharmacology, Toxico…Earth and Planetary Sciences: 0.48× its world share, 0 worksEarth and Planetary …Engineering: 0.06× its world share, 0 worksEngineeringEnvironmental Science: 0.20× its world share, 0 worksEnvironmental ScienceMedicine: 4.02× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 1.71× its world share, 0 worksEconomics, Econometr…Psychology: 1.29× its world share, 0 worksPsychologySocial Sciences: 0.16× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Immunology and Microbiology, 4.5×. Every wedge is a field page.

Who are the top researchers at GlaxoSmithKline (Sweden)?

Ranked on the composite score, Bengt Jacobsson lead among researchers whose main affiliation is GlaxoSmithKline (Sweden).

  1. 1 Bengt Jacobsson Sweden · #473,696 worldwide 47 citations · 41 works
All ranked researchers at GlaxoSmithKline (Sweden)

Which keywords describe research at GlaxoSmithKline (Sweden)?

By fractional works in all years, weighted toward what it does more of than the world: Epidemiology, Pragmatics, Vaccine, Phylogeny, Conservation, Biogeography, Pathogenesis and Semantics.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 31 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 31 words, with their numbers
  1. Epidemiology6▲ 4.0×24 topics
  2. Pragmatics3▲ 46×3 topics
  3. Vaccine3▲ 17×6 topics
  4. Phylogeny2▲ 33×4 topics
  5. Biogeography2▲ 17×5 topics
  6. Conservation2▲ 12×3 topics
  7. Inflammation2▲ 2.3×9 topics
  8. Pathogenesis2▲ 9.0×6 topics
  9. Climate Change2▲ 1.75×6 topics
  10. Semantics2▲ 137×1 topic
  11. Syntax2▲ 65×1 topic
  12. Invasive Species2▲ 7.3×2 topics
  13. Taxonomy2▲ 28×2 topics
  14. Treatment2▲ 3.4×8 topics
  15. Diagnosis2▲ 4.0×7 topics
  16. Immune Response2▲ 6.5×5 topics
  17. Genetics2▲ 4.9×3 topics
  18. Management2▲ 5.0×5 topics
  19. Biodiversity1▲ 4.7×2 topics
  20. Quality of Life1▲ 2.6×8 topics
  21. Medicinal Plants1▲ 9.1×3 topics
  22. Respiratory1▲ 32×2 topics
  23. Evolution1▲ 10×2 topics
  24. Allergic Diseases1▲ 35×1 topic
  25. Asthma1▲ 23×2 topics
  26. Autoantibodies1▲ 12×3 topics
  27. Eosinophils1▲ 35×1 topic
  28. Clinical Management1▲ 13×2 topics
  29. Dictionaries1▲ 65×1 topic
  30. Lexicography1▲ 24×1 topic
  31. Perception1▲ 33×2 topics

Which research topics does GlaxoSmithKline (Sweden) publish most on?

By volume in 2022–2025: Multiple Myeloma Research and Treatments, Herpesvirus Infections and Treatments, Gallbladder and Bile Duct Disorders and Pediatric Hepatobiliary Diseases and Treatments.

Multiple Myeloma Research and Treatments: 1 fractional worksHerpesvirus Infections and Treatments: 1 fractional worksGallbladder and Bile Duc…0Gallbladder and Bile Duct Disorders: 0 fractional worksPediatric Hepatobiliary …0Pediatric Hepatobiliary Diseases and Treatments: 0 fractional worksLiver Diseases and Immunity: 0 fractional worksInsect Utilization and Effects: 0 fractional worksAnimal and Plant Science…0Animal and Plant Science Education: 0 fractional worksVirology and Viral Diseases: 0 fractional worksCancer Immunotherapy and Biomarkers: 0 fractional worksAsthma and respiratory diseases: 0 fractional works
HematologyEpidemiologyPulmonary and Respiratory MedicineSurgery5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Multiple Myeloma Research and Treatments Hematology 1 works
  2. 2 Herpesvirus Infections and Treatments Epidemiology 1 works
  3. 3 Gallbladder and Bile Duct Disorders Pulmonary and Respiratory Medicine 0 works
  4. 4 Pediatric Hepatobiliary Diseases and Treatments Surgery 0 works
  5. 5 Liver Diseases and Immunity Hepatology 0 works
  6. 6 Insect Utilization and Effects Insect Science 0 works
  7. 7 Animal and Plant Science Education Social Psychology 0 works
  8. 8 Virology and Viral Diseases Epidemiology 0 works
  9. 9 Cancer Immunotherapy and Biomarkers Oncology 0 works
  10. 10 Asthma and respiratory diseases Physiology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available38.9%not open61.1%

World: 28% of research is openly available.

with international co-authors40.3%domestic only59.7%

World: 19% is written across borders.

How has GlaxoSmithKline (Sweden)'s research output changed?

Output in 2018–2022 was 56% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Solna

All research institutions in Solna

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.